Which cycle gains the most absolute strength?

The Test + Tren + Anadrol combo remains historically the most effective for absolute strength (+20-35 kg on 3 lifts in 12 wk in advanced users). Mechanisms: Test provides androgen base and erythropoiesis, Tren amplifies neural drive and tissue-selective protein synthesis (Yarrow 2011), Anadrol kickstarts joint and glycogen hydration for immediate explosiveness. Very heavy risk profile: blood pressure, liver, lipids, ASIH. Reserved for elite competitors accepting this profile and with strict monitoring. For the majority, Test E 500 + Sustanon 500 (effective 900 mg/wk) or Test + moderate Tren offer 80% of the result with less risk.

AAS and tendons: rupture risk?

Real and documented. AAS amplify muscle strength faster than tendon resistance adapts — imbalance risk of rupture on absolute loads. Particularly marked with Winstrol and Halotestin (dry synovial structures), less with testosterone alone. Cohort studies (Sader 2001) suggest altered collagen quality under chronic AAS. Precautions: (1) Progressive load on cycle (don't attempt 1RM too early). (2) Extensive warmup (15-20 min). (3) 'Lubricating' compounds (Deca, Primo) if joint history. (4) Joint support: hydrolyzed collagen 15 g/d, omega-3 3 g/d, vitamin C 1 g/d, hydration +1L/d.

Strength cycle vs mass cycle: differences?

Main differences: (1) Favored compounds: strength cycles oriented toward Tren, Anadrol, Halotestin, strong Test base; mass cycles toward Test + Deca, moderate Test + Dbol, Primo. (2) Training programming: strength = moderate volume, intensity 85-95% 1RM, long rest; mass = high volume, intensity 65-80% 1RM, moderate rest. (3) Nutrition: strength = moderate surplus (+200-300 kcal), elevated protein 2.2-2.5 g/kg; mass = generous surplus (+400-600 kcal), protein 2 g/kg. (4) Duration: strength = short intense cycles (8-12 wk); mass = long cycles (12-16 wk). (5) PCT: strength requires faster neural recovery, pre-PCT hCG often useful.

Tested powerlifting: possible with AAS?

Not without sporting risk. Tested federations (IPF, USAPL pre-2021, WPC) use WADA-compliant controls (Sobolevsky 2012 on long-term Turinabol metabolites — 12-18 month detection). All AAS are on the WADA S1 list, variable but often long detection. Strategies (for record, not recommended): prolonged pause (>18 months) before tested competition, very short cycles with short esters (test propionate), short-detection half-life molecules. In practice: if you want to compete tested, stay natural. If you want to compete with AAS, choose untested federations (USPA, WPO, GPC, strongman federations).

How to manage blood pressure on strength cycle?

Critical surveillance. Heavy strength stacks (Tren, Anadrol, M1T) systematically elevate blood pressure (Hartgens 2004, Baggish 2017). Monitoring: daily morning + evening readings at rest over 5 min. Targets: 150/95: (1) Reduce dose. (2) Add telmisartan 20-40 mg/d (often used bodybuilding, ideal medical supervision). (3) Optimize sleep 8h, sodium 160/100: cycle stop, consultation. Lifestyle factors: coffee, sleep, stress, salt — all matter.

Halotestin: rational use?

Strictly reserved for last 2-4 wk pre-meet, dose 10-20 mg/d. Beneficial effect: absolute strength +5-10% by neural drive and subjective confidence without mass gain (so stable weight category). Risk profile: among the highest hepatotoxicity of orals (Hudson 1959, Niedfeldt 2018), sometimes excessive marked aggression ('halo-rage'), catastrophic lipid profile. Precautions: weekly ALT/AST, high-dose hepatoprotectors (TUDCA 1000 mg/d, NAC 1800 mg/d), stop 3-5 days before meet to eliminate hepatic peak. Not in off-season or outside competition.

What role for peptides in strength cycle?

Complementary. GH-stimulating peptides (Ipamorelin, GHRP-2, CJC-1295) improve inter-session recovery and deep sleep — indirect benefits on strength (optimized neural recovery). Oral MK-677 provides same effects without injection. BPC-157 useful in post-joint or tendon injury rehabilitation, frequent in heavy powerlifters and strongmen. IGF-1 LR3 adds direct anabolic effect but hypoglycemia risk. In practice: Ipamorelin 100 µg x 2/d routine good option, BPC-157 250 µg/d targeted recovery if injury. No replacement for AAS for absolute strength.

Strength cycle after 40: adaptations?

Specific master recommendations. (1) Prefer mild compounds (moderate Test E 400-500 mg/wk, add Primo 400 mg/wk or Anavar 30 mg/d) rather than Tren/Anadrol. (2) Shorter cycles (8-10 wk) with longer offs. (3) Reinforced cardiovascular monitoring (ECG, echocardiography if history). (4) Systematic joint support (collagen, omega-3, glucosamine). (5) Sleep priority (8h+, GH secretagogues useful). (6) Bloodwork every 3 months (including PSA). (7) Consider medicalized blast & cruise with permanent TRT rather than repeated cycles with PCT in >45 (Bhasin 2018). Absolute strength is less than at 25, but progression still possible.

Best strength cycles in 2026 — 10 powerlifting/strongman protocols

Methodology

Rankings based on 4 weighted criteria specific to strength cycles. (1) Effect on absolute strength: percentage increase of the 3 powerlifting movements (squat, bench, deadlift) over 8-12 weeks of cycle with optimized strength programming. Bhasin 1996 (NEJM) baseline: +22% bench at 600 mg/wk testosterone for 10 wk. (2) Neuromuscular effect: neural drive, gym aggression (useful for 1RM), pre-lift confidence — particularly marked with trenbolone and halotestin. (3) Joint and tendon safety: collagen preservation (nandrolone, primobolan), tendon rupture risk (winstrol, halotestin dry synovial structures). (4) Fit with competition vs off-season profile: tested powerlifting (banned all AAS), non-tested powerlifting (USPA, untested USAPL), strongman (largely AAS-permissive). Primary sources: Bhasin 1996, Yarrow 2011 (trenbolone tissue-selective anabolic), Hartgens 2004, Hudson 1959 (fluoxymesterone), Hengge 2003 (oxymetholone).

1. Test E 500 mg/wk + Anadrol 75 mg/d (4 wk kickstart) — the "big bench" cycle
The historic combo of heavy powerlifters: moderate testosterone + oxymetholone (Anadrol) at 75 mg/d as kickstart. Anadrol massively increases joint and glycogen water retention, amplifies erythropoiesis, and provides 'explosive' strength at W2-W4. 1RM bench gains: +15-25 kg over 8 wk. Hengge 2003 documents anabolic effect of oxymetholone in HIV (+3.3 kg lean mass in 16 wk at 50 mg/d without training).
Dose / Duration
Test enanthate 500 mg/wk for 12-14 wk + Anadrol 50-75 mg/d during W1-W4 (kickstart). AI mandatory (anastrozole 1 mg E2D high Anadrol dose). Continuous hepatoprotectors. Classic PCT Nolva + Clomid.
Target audience
Advanced powerlifters and strongmen (4+ cycles), off-season outside tested competition, excellent baseline cardiovascular, weight category tolerant to gain. Not on first strength cycle.
Pros
- + Immediate absolute strength effect (W2-W4)
- + Marked erythropoiesis increase (endurance)
- + Joint retention ("lubrication") favorable for heavy lifts
- + Amplified protein synthesis (Hengge 2003)
- + Moderate cost (accessible UGL Anadrol)
Cons
- − Among the highest hepatotoxicity (Niedfeldt 2018)
- − Massive water retention (changing weight category)
- − Elevated blood pressure
- − Headaches, lethargy in 30-40% of users
- − Catastrophic lipid profile
2. Test E 500 + Tren A 75 mg E2D (8 wk) — the "meet cycle"
The 'king stack' of untested powerlifting: testosterone + trenbolone acetate. Tren A amplifies neural strength, aggression, and psychological drive — precious for max attempts. Yarrow 2011 documents tissue-selective anabolic effect of trenbolone. Short kinetics (E2D inj) allow fine control and rapid stop. Heavy side-effect profile: sweats, insomnia, anxiety, blood pressure.
Dose / Duration
Test enanthate 500 mg/wk + Trenbolone acetate 75 mg E2D for 6-8 wk. AI mandatory. Cabergoline 0.25 mg 2x/wk on reserve. Classic PCT with pre-PCT hCG.
Target audience
Untested powerlifters and strongmen in competition prep, advanced users (5+ cycles), stable psychology. Not for tested athletes or anxious users.
Pros
- + Maximum absolute strength effect
- + Neural drive and "lift mode" aggression
- + Recomposition possible (strength + cutting)
- + Short kinetics: rapid stop possible
- + Well-documented test + tren synergy
Cons
- − Night sweats, insomnia, anxiety (Pope 2000)
- − Very elevated blood pressure (Baggish 2017)
- − Tren-cough on injection (frequent)
- − Long HPG recovery (5-8 months)
- − Demanding E2D injection
3. Test E 500 + Tren E 300 mg/wk + Anadrol 50 mg/d (kickstart) — the "monster strength"
Extreme strength stack combining three axes: androgen base (Test), tissue-selective + neural (Tren E), water + erythropoiesis kickstart (Anadrol). Exceptional 1RM gains: +20-35 kg on the 3 lifts in 12 wk. Very unfavorable cardiovascular and lipid profile. End-of-competitive-career stack for absolute records.
Dose / Duration
Test E 500 mg/wk + Tren E 300 mg/wk for 12 wk + Anadrol 50 mg/d during W1-W4. AI mandatory (anastrozole 1 mg E2D). Cabergoline 0.5 mg 2x/wk. Continuous hepatoprotectors. Quarterly biological monitoring.
Target audience
Elite powerlifters and strongmen (10+ cumulative cycles), peak competitive career, established medical monitoring, exceptional baseline cardiovascular. Not for recurrent use.
Pros
- + Historically maximum documented strength gains
- + 3 complementary mechanism synergy
- + Record "lift confidence" psychological effect
- + Simultaneous absolute strength and mass
- + Suited to elite records
Cons
- − Major cardiovascular risk (Baggish 2017)
- − Systematically elevated blood pressure
- − Stressed liver (Anadrol)
- − Difficult PCT, possible ASIH
- − Catastrophic lipid profile
4. Test E 500 + Deca 400 + Dbol 30 mg/d (kickstart) — the "Arnold strength cycle"
The historical protocol of 1970-1990 classic powerlifting: Test + Deca + Dbol. Combines Dbol kickstart for initial strength, Test base, and Deca for joint preservation (collagen and synovial effect — appreciated on heavy deadlift). Hartgens 2004 documents effect on composition and lipid profile. Difficult PCT (deca + long ester).
Dose / Duration
Test E 500 mg/wk + Nandrolone decanoate 400 mg/wk for 14 wk + Dianabol 30-40 mg/d during W1-W4. hCG 500 IU 2x/wk from W2. AI mandatory. Classic PCT with pre-PCT hCG.
Target audience
Advanced powerlifters and strongmen (4+ cycles), off-season, deadlift/squat focus, sensitive baseline joints. Not in immediate pre-meet cycle (weight category water retention).
Pros
- + Positive joint effect (deca, lubrication)
- + Record strength during Dbol kickstart window
- + 3-mechanism synergy
- + Favorable joint profile for deadlift
- + Massively empirically validated
Cons
- − Deep HPG suppression (Deca + Test)
- − Prolactin risk (deca-dick + depression)
- − Dbol hepatotoxicity
- − Demanding PCT
- − Very long anti-doping detection (nandrolone)
5. Test E + Halotestin 20 mg/d (4 wk as finisher) — the "pure strength" cycle
Halotestin (fluoxymesterone) is the most androgenic and most hepatotoxic oral in AAS landscape, reserved for the last 4 weeks pre-meet for 'pure strength' effect without mass or retention. Massively increases neural strength, aggression and 'pre-lift' confidence. Hudson 1959 describes its profile. Very short use (max 4 wk) exclusively in advanced competitors.
Dose / Duration
Test enanthate 250-400 mg/wk for 10 wk + Halotestin 10-20 mg/d for last 4 wk pre-meet. AI as needed. High-dose hepatoprotectors. Weekly liver bloodwork.
Target audience
Elite powerlifters and strongmen (5+ cycles), pre-meet 4 wk before competition, medical support and biological monitoring. Strictly not recommended outside competition.
Pros
- + Maximum strength and power pre-competition
- + No water retention (stable weight category)
- + Record "lift confidence" psychological effect
- + Marked visual hardness
- + Fast elimination post-stop
Cons
- − Among the highest hepatotoxicity of orals (Hudson 1959)
- − Marked aggression ("halo-rage", Pope 2000)
- − Catastrophic lipid profile
- − High cost
- − Very limited black-market availability
6. Test E 400 + Sustanon 500 mg/wk for 12 wk — the "strength-power" cycle
Strength variant oriented toward pure testosterone at moderate-high dose (900 mg/wk effective). Testosterone remains the best-studied androgen for strength effect (Bhasin 1996 NEJM: +22% bench at 600 mg/wk for 10 wk). At cumulative 900 mg/wk, 1RM bench gains +20-30 kg. Less heavy profile than tren/anadrol stacks.
Dose / Duration
Test E 400 mg/wk + Sustanon 500 mg/wk for 12 wk (equivalent ~900 mg total test). AI mandatory at high dose (anastrozole 0.5 mg E2D). Classic PCT with pre-PCT hCG.
Target audience
Intermediate powerlifters (2-3 cycles), seeking a strength cycle without tren/orals complexity, correct baseline cardiovascular. Good first dedicated 'strength' cycle.
Pros
- + Documented strength effect (Bhasin 1996)
- + Better tolerance profile than tren/anadrol stacks
- + No 17α-alkylated oral
- + Accessible cost
- + Wide availability of both products
Cons
- − Marked aromatization at 900 mg/wk
- − Significant water retention
- − Hematocrit to monitor
- − Deep HPG suppression
- − Acne and balding depending on genetics
7. Test E + Primobolan 400 mg/wk + Anavar 40 mg/d — the joint-friendly "light strength"
Strength variant oriented toward joint preservation and aesthetic profile. Primo and Anavar don't aromatize, little retention, preserved joints. Modest strength gains (+10-15 kg bench/squat) but exceptionally 'clean' profile. Very high cost. Suited to strength athletes with sensitive joint history.
Dose / Duration
Test enanthate 300 mg/wk + Methenolone enanthate 400 mg/wk for 12 wk + Anavar 40 mg/d for 8 wk. AI rarely needed. Hepatoprotectors (Anavar). Classic PCT.
Target audience
Strength athletes with joint history (tendinitis, recurrent pain), masters >40, long-term health focus, substantial budget. Not for pure brute records.
Pros
- + Excellent joint profile
- + No retention (stable weight category)
- + Excellent overall tolerance
- + Aesthetic: "clean" gain
- + Low HPG suppression
Cons
- − Exorbitant cost (~$700-1000 cycle)
- − Modest strength gains vs tren stacks
- − Frequent Primo and Anavar counterfeits
- − Limited "brute force" effect
- − Not for absolute records
8. Test C 200 mg/wk + Tren E 200 mg/wk (recomposition strength) — the "steady state"
Moderate strength stack oriented toward recomposition + progressive strength. Moderate doses of both compounds allow long cycle (10-14 wk) with simultaneous strength and lean mass gains. Moderate tren neural drive (not excessive), good overall tolerance. Suited to intermediate athletes in regular strength progression.
Dose / Duration
Test cypionate 200 mg/wk + Trenbolone enanthate 200 mg/wk for 10-14 wk. Titrated AI (anastrozole 0.25 mg E3D). Classic PCT with pre-PCT hCG.
Target audience
Intermediate strength athletes (2-3 cycles), recomposition vs pure cut, stable psychology, seeking a 'steady' cycle without side-effect peak. Good 'durable' strength cycle.
Pros
- + Recomposition: strength + mass + fat loss
- + Better tolerance than aggressive tren stacks
- + Simple logistics (2 inj/wk)
- + Viable long cycle
- + Moderate cost
Cons
- − Tren effect: moderate sweats, insomnia
- − Elevated blood pressure
- − Deep HPG suppression
- − Not for anxious users
- − Long anti-doping detection
9. Test E 500 + Turinabol 60 mg/d for 6 wk — the "dry strength kickstart"
Strength variant oriented toward milder oral: Turinabol (chlorodehydromethyltestosterone) at 60 mg/d for 6 wk instead of Dbol/Anadrol. Tbol provides regular strength gains without massive retention, moderate hepatotoxicity vs other orals. 'Clean' profile for visual strength. Sobolevsky 2012 documents long-term metabolites (12-18 month detection — not for tested athletes).
Dose / Duration
Test enanthate 500 mg/wk for 12 wk + Turinabol 60 mg/d during W1-W6 (kickstart). AI as needed. Hepatoprotectors W1-W6. Classic PCT.
Target audience
Intermediate powerlifters and strongmen (3+ cycles), seeking a 'clean' oral kickstart, solid baseline liver, athletes in untested sport. Not for tested athletes (Tbol detectable very long).
Pros
- + Milder oral than Dbol/Anadrol
- + No massive retention
- + Regular strength gains
- + Clean visual effect
- + Moderate cost
Cons
- − Moderate hepatotoxicity (17α-alkylated)
- − Degraded lipid profile
- − Very long anti-doping detection (Sobolevsky 2012)
- − Raw effect inferior to Anadrol
- − Black market: frequent counterfeits
10. Sustanon 500 + Boldenone 600 + M1T 10 mg/d — the "EQ strength stack"
Variant oriented toward Boldenone (Equipoise) for endurance and appetite, combined with a 'designer steroid' oral like methyl-1-testosterone (M1T) at low dose. M1T is extremely potent per mg but severely hepatotoxic. Limit to 10 mg/d for 4 wk max. Aggressive profile on strength and endurance, suited to strongman. Critical liver bloodwork.
Dose / Duration
Sustanon 500 mg/wk + Boldenone undecylenate 600 mg/wk for 14-16 wk + M1T 10 mg/d during W1-W4. AI mandatory. Very high-dose hepatoprotectors. Demanding PCT with pre-PCT hCG.
Target audience
Elite strongmen accepting M1T risk profile, long strongman off-season, monthly biological monitoring. Strictly not recommended outside professional strongman competitive profile.
Pros
- + Endurance + strength effect (Boldenone)
- + M1T extremely potent per mg
- + Suited to strongman (endurance event)
- + Increased erythropoiesis (Bold)
- + Appetite effect (useful strongman caloric intake)
Cons
- − M1T among the most severe hepatotoxicity
- − Very elevated hematocrit (probable phlebotomies)
- − Elevated blood pressure
- − Long cycle (14-16 wk) — significant commitment
- − Catastrophic lipid profile

Final comparison

Stack	1RM bench gain 8 wk	Joints	Weight category	Safety
Test + Anadrol	+15-25 kg	Lubricated (water)	Marked change	Medium-low
Test + Tren A	+15-25 kg	Dry (risk)	Stable	Low
Test + Tren + Anadrol	+20-35 kg	Mixed	Variable	Very low
Test + Deca + Dbol	+15-25 kg	Very good (deca)	Marked change	Low
Test + Halotestin	+10-20 kg	Dry (risk)	Stable	Low (liver)
Test 900 mg/wk solo	+15-25 kg	Lubricated	Moderate change	Medium
Test + Primo + Anavar	+10-15 kg	Good	Stable	Good
Test + Tren E (steady)	+12-20 kg	Moderately dry	Stable	Medium
Test + Turinabol	+12-20 kg	Neutral	Moderate	Medium
Sustanon + EQ + M1T	+15-25 kg	Good (EQ)	Marked change	Very low (M1T)

FAQ

Which cycle gains the most absolute strength?: The Test + Tren + Anadrol combo remains historically the most effective for absolute strength (+20-35 kg on 3 lifts in 12 wk in advanced users). Mechanisms: Test provides androgen base and erythropoiesis, Tren amplifies neural drive and tissue-selective protein synthesis (Yarrow 2011), Anadrol kickstarts joint and glycogen hydration for immediate explosiveness. Very heavy risk profile: blood pressure, liver, lipids, ASIH. Reserved for elite competitors accepting this profile and with strict monitoring. For the majority, Test E 500 + Sustanon 500 (effective 900 mg/wk) or Test + moderate Tren offer 80% of the result with less risk.
AAS and tendons: rupture risk?: Real and documented. AAS amplify muscle strength faster than tendon resistance adapts — imbalance risk of rupture on absolute loads. Particularly marked with Winstrol and Halotestin (dry synovial structures), less with testosterone alone. Cohort studies (Sader 2001) suggest altered collagen quality under chronic AAS. Precautions: (1) Progressive load on cycle (don't attempt 1RM too early). (2) Extensive warmup (15-20 min). (3) 'Lubricating' compounds (Deca, Primo) if joint history. (4) Joint support: hydrolyzed collagen 15 g/d, omega-3 3 g/d, vitamin C 1 g/d, hydration +1L/d.
Strength cycle vs mass cycle: differences?: Main differences: (1) Favored compounds: strength cycles oriented toward Tren, Anadrol, Halotestin, strong Test base; mass cycles toward Test + Deca, moderate Test + Dbol, Primo. (2) Training programming: strength = moderate volume, intensity 85-95% 1RM, long rest; mass = high volume, intensity 65-80% 1RM, moderate rest. (3) Nutrition: strength = moderate surplus (+200-300 kcal), elevated protein 2.2-2.5 g/kg; mass = generous surplus (+400-600 kcal), protein 2 g/kg. (4) Duration: strength = short intense cycles (8-12 wk); mass = long cycles (12-16 wk). (5) PCT: strength requires faster neural recovery, pre-PCT hCG often useful.
Tested powerlifting: possible with AAS?: Not without sporting risk. Tested federations (IPF, USAPL pre-2021, WPC) use WADA-compliant controls (Sobolevsky 2012 on long-term Turinabol metabolites — 12-18 month detection). All AAS are on the WADA S1 list, variable but often long detection. Strategies (for record, not recommended): prolonged pause (>18 months) before tested competition, very short cycles with short esters (test propionate), short-detection half-life molecules. In practice: if you want to compete tested, stay natural. If you want to compete with AAS, choose untested federations (USPA, WPO, GPC, strongman federations).
How to manage blood pressure on strength cycle?: Critical surveillance. Heavy strength stacks (Tren, Anadrol, M1T) systematically elevate blood pressure (Hartgens 2004, Baggish 2017). Monitoring: daily morning + evening readings at rest over 5 min. Targets: <140/90, ideally <130/85. If sustained BP >150/95: (1) Reduce dose. (2) Add telmisartan 20-40 mg/d (often used bodybuilding, ideal medical supervision). (3) Optimize sleep 8h, sodium <4 g/d, hydration. (4) Cardio LISS 3x/wk 30 min. If repeat BP >160/100: cycle stop, consultation. Lifestyle factors: coffee, sleep, stress, salt — all matter.
Halotestin: rational use?: Strictly reserved for last 2-4 wk pre-meet, dose 10-20 mg/d. Beneficial effect: absolute strength +5-10% by neural drive and subjective confidence without mass gain (so stable weight category). Risk profile: among the highest hepatotoxicity of orals (Hudson 1959, Niedfeldt 2018), sometimes excessive marked aggression ('halo-rage'), catastrophic lipid profile. Precautions: weekly ALT/AST, high-dose hepatoprotectors (TUDCA 1000 mg/d, NAC 1800 mg/d), stop 3-5 days before meet to eliminate hepatic peak. Not in off-season or outside competition.
What role for peptides in strength cycle?: Complementary. GH-stimulating peptides (Ipamorelin, GHRP-2, CJC-1295) improve inter-session recovery and deep sleep — indirect benefits on strength (optimized neural recovery). Oral MK-677 provides same effects without injection. BPC-157 useful in post-joint or tendon injury rehabilitation, frequent in heavy powerlifters and strongmen. IGF-1 LR3 adds direct anabolic effect but hypoglycemia risk. In practice: Ipamorelin 100 µg x 2/d routine good option, BPC-157 250 µg/d targeted recovery if injury. No replacement for AAS for absolute strength.
Strength cycle after 40: adaptations?: Specific master recommendations. (1) Prefer mild compounds (moderate Test E 400-500 mg/wk, add Primo 400 mg/wk or Anavar 30 mg/d) rather than Tren/Anadrol. (2) Shorter cycles (8-10 wk) with longer offs. (3) Reinforced cardiovascular monitoring (ECG, echocardiography if history). (4) Systematic joint support (collagen, omega-3, glucosamine). (5) Sleep priority (8h+, GH secretagogues useful). (6) Bloodwork every 3 months (including PSA). (7) Consider medicalized blast & cruise with permanent TRT rather than repeated cycles with PCT in >45 (Bhasin 2018). Absolute strength is less than at 25, but progression still possible.

Best strength cycles in 2026 — 10 powerlifting/strongman protocols

Methodology

1. Test E 500 mg/wk + Anadrol 75 mg/d (4 wk kickstart) — the "big bench" cycle

The historic combo of heavy powerlifters: moderate testosterone + oxymetholone (Anadrol) at 75 mg/d as kickstart. Anadrol massively increases joint and glycogen water retention, amplifies erythropoiesis, and provides 'explosive' strength at W2-W4. 1RM bench gains: +15-25 kg over 8 wk. Hengge 2003 documents anabolic effect of oxymetholone in HIV (+3.3 kg lean mass in 16 wk at 50 mg/d without training).

Dose / Duration

Test enanthate 500 mg/wk for 12-14 wk + Anadrol 50-75 mg/d during W1-W4 (kickstart). AI mandatory (anastrozole 1 mg E2D high Anadrol dose). Continuous hepatoprotectors. Classic PCT Nolva + Clomid.

Target audience

Advanced powerlifters and strongmen (4+ cycles), off-season outside tested competition, excellent baseline cardiovascular, weight category tolerant to gain. Not on first strength cycle.

Pros

+ Immediate absolute strength effect (W2-W4)
+ Marked erythropoiesis increase (endurance)
+ Joint retention ("lubrication") favorable for heavy lifts
+ Amplified protein synthesis (Hengge 2003)
+ Moderate cost (accessible UGL Anadrol)

Cons

− Among the highest hepatotoxicity (Niedfeldt 2018)
− Massive water retention (changing weight category)
− Elevated blood pressure
− Headaches, lethargy in 30-40% of users
− Catastrophic lipid profile

2. Test E 500 + Tren A 75 mg E2D (8 wk) — the "meet cycle"

The 'king stack' of untested powerlifting: testosterone + trenbolone acetate. Tren A amplifies neural strength, aggression, and psychological drive — precious for max attempts. Yarrow 2011 documents tissue-selective anabolic effect of trenbolone. Short kinetics (E2D inj) allow fine control and rapid stop. Heavy side-effect profile: sweats, insomnia, anxiety, blood pressure.

Dose / Duration

Test enanthate 500 mg/wk + Trenbolone acetate 75 mg E2D for 6-8 wk. AI mandatory. Cabergoline 0.25 mg 2x/wk on reserve. Classic PCT with pre-PCT hCG.

Target audience

Untested powerlifters and strongmen in competition prep, advanced users (5+ cycles), stable psychology. Not for tested athletes or anxious users.

Pros

+ Maximum absolute strength effect
+ Neural drive and "lift mode" aggression
+ Recomposition possible (strength + cutting)
+ Short kinetics: rapid stop possible
+ Well-documented test + tren synergy

Cons

− Night sweats, insomnia, anxiety (Pope 2000)
− Very elevated blood pressure (Baggish 2017)
− Tren-cough on injection (frequent)
− Long HPG recovery (5-8 months)
− Demanding E2D injection

3. Test E 500 + Tren E 300 mg/wk + Anadrol 50 mg/d (kickstart) — the "monster strength"

Extreme strength stack combining three axes: androgen base (Test), tissue-selective + neural (Tren E), water + erythropoiesis kickstart (Anadrol). Exceptional 1RM gains: +20-35 kg on the 3 lifts in 12 wk. Very unfavorable cardiovascular and lipid profile. End-of-competitive-career stack for absolute records.

Dose / Duration

Test E 500 mg/wk + Tren E 300 mg/wk for 12 wk + Anadrol 50 mg/d during W1-W4. AI mandatory (anastrozole 1 mg E2D). Cabergoline 0.5 mg 2x/wk. Continuous hepatoprotectors. Quarterly biological monitoring.

Target audience

Elite powerlifters and strongmen (10+ cumulative cycles), peak competitive career, established medical monitoring, exceptional baseline cardiovascular. Not for recurrent use.

Pros

+ Historically maximum documented strength gains
+ 3 complementary mechanism synergy
+ Record "lift confidence" psychological effect
+ Simultaneous absolute strength and mass
+ Suited to elite records

Cons

− Major cardiovascular risk (Baggish 2017)
− Systematically elevated blood pressure
− Stressed liver (Anadrol)
− Difficult PCT, possible ASIH
− Catastrophic lipid profile

4. Test E 500 + Deca 400 + Dbol 30 mg/d (kickstart) — the "Arnold strength cycle"

The historical protocol of 1970-1990 classic powerlifting: Test + Deca + Dbol. Combines Dbol kickstart for initial strength, Test base, and Deca for joint preservation (collagen and synovial effect — appreciated on heavy deadlift). Hartgens 2004 documents effect on composition and lipid profile. Difficult PCT (deca + long ester).

Dose / Duration

Test E 500 mg/wk + Nandrolone decanoate 400 mg/wk for 14 wk + Dianabol 30-40 mg/d during W1-W4. hCG 500 IU 2x/wk from W2. AI mandatory. Classic PCT with pre-PCT hCG.

Target audience

Advanced powerlifters and strongmen (4+ cycles), off-season, deadlift/squat focus, sensitive baseline joints. Not in immediate pre-meet cycle (weight category water retention).

Pros

+ Positive joint effect (deca, lubrication)
+ Record strength during Dbol kickstart window
+ 3-mechanism synergy
+ Favorable joint profile for deadlift
+ Massively empirically validated

Cons

− Deep HPG suppression (Deca + Test)
− Prolactin risk (deca-dick + depression)
− Dbol hepatotoxicity
− Demanding PCT
− Very long anti-doping detection (nandrolone)

5. Test E + Halotestin 20 mg/d (4 wk as finisher) — the "pure strength" cycle

Halotestin (fluoxymesterone) is the most androgenic and most hepatotoxic oral in AAS landscape, reserved for the last 4 weeks pre-meet for 'pure strength' effect without mass or retention. Massively increases neural strength, aggression and 'pre-lift' confidence. Hudson 1959 describes its profile. Very short use (max 4 wk) exclusively in advanced competitors.

Dose / Duration

Test enanthate 250-400 mg/wk for 10 wk + Halotestin 10-20 mg/d for last 4 wk pre-meet. AI as needed. High-dose hepatoprotectors. Weekly liver bloodwork.

Target audience

Elite powerlifters and strongmen (5+ cycles), pre-meet 4 wk before competition, medical support and biological monitoring. Strictly not recommended outside competition.

Pros

+ Maximum strength and power pre-competition
+ No water retention (stable weight category)
+ Record "lift confidence" psychological effect
+ Marked visual hardness
+ Fast elimination post-stop

Cons

− Among the highest hepatotoxicity of orals (Hudson 1959)
− Marked aggression ("halo-rage", Pope 2000)
− Catastrophic lipid profile
− High cost
− Very limited black-market availability

6. Test E 400 + Sustanon 500 mg/wk for 12 wk — the "strength-power" cycle

Strength variant oriented toward pure testosterone at moderate-high dose (900 mg/wk effective). Testosterone remains the best-studied androgen for strength effect (Bhasin 1996 NEJM: +22% bench at 600 mg/wk for 10 wk). At cumulative 900 mg/wk, 1RM bench gains +20-30 kg. Less heavy profile than tren/anadrol stacks.

Dose / Duration

Test E 400 mg/wk + Sustanon 500 mg/wk for 12 wk (equivalent ~900 mg total test). AI mandatory at high dose (anastrozole 0.5 mg E2D). Classic PCT with pre-PCT hCG.

Target audience

Intermediate powerlifters (2-3 cycles), seeking a strength cycle without tren/orals complexity, correct baseline cardiovascular. Good first dedicated 'strength' cycle.

Pros

+ Documented strength effect (Bhasin 1996)
+ Better tolerance profile than tren/anadrol stacks
+ No 17α-alkylated oral
+ Accessible cost
+ Wide availability of both products

Cons

− Marked aromatization at 900 mg/wk
− Significant water retention
− Hematocrit to monitor
− Deep HPG suppression
− Acne and balding depending on genetics

7. Test E + Primobolan 400 mg/wk + Anavar 40 mg/d — the joint-friendly "light strength"

Strength variant oriented toward joint preservation and aesthetic profile. Primo and Anavar don't aromatize, little retention, preserved joints. Modest strength gains (+10-15 kg bench/squat) but exceptionally 'clean' profile. Very high cost. Suited to strength athletes with sensitive joint history.

Dose / Duration

Test enanthate 300 mg/wk + Methenolone enanthate 400 mg/wk for 12 wk + Anavar 40 mg/d for 8 wk. AI rarely needed. Hepatoprotectors (Anavar). Classic PCT.

Target audience

Strength athletes with joint history (tendinitis, recurrent pain), masters >40, long-term health focus, substantial budget. Not for pure brute records.

Pros

+ Excellent joint profile
+ No retention (stable weight category)
+ Excellent overall tolerance
+ Aesthetic: "clean" gain
+ Low HPG suppression

Cons

− Exorbitant cost (~$700-1000 cycle)
− Modest strength gains vs tren stacks
− Frequent Primo and Anavar counterfeits
− Limited "brute force" effect
− Not for absolute records

8. Test C 200 mg/wk + Tren E 200 mg/wk (recomposition strength) — the "steady state"

Moderate strength stack oriented toward recomposition + progressive strength. Moderate doses of both compounds allow long cycle (10-14 wk) with simultaneous strength and lean mass gains. Moderate tren neural drive (not excessive), good overall tolerance. Suited to intermediate athletes in regular strength progression.

Dose / Duration

Test cypionate 200 mg/wk + Trenbolone enanthate 200 mg/wk for 10-14 wk. Titrated AI (anastrozole 0.25 mg E3D). Classic PCT with pre-PCT hCG.

Target audience

Intermediate strength athletes (2-3 cycles), recomposition vs pure cut, stable psychology, seeking a 'steady' cycle without side-effect peak. Good 'durable' strength cycle.

Pros

+ Recomposition: strength + mass + fat loss
+ Better tolerance than aggressive tren stacks
+ Simple logistics (2 inj/wk)
+ Viable long cycle
+ Moderate cost

Cons

− Tren effect: moderate sweats, insomnia
− Elevated blood pressure
− Deep HPG suppression
− Not for anxious users
− Long anti-doping detection

9. Test E 500 + Turinabol 60 mg/d for 6 wk — the "dry strength kickstart"

Strength variant oriented toward milder oral: Turinabol (chlorodehydromethyltestosterone) at 60 mg/d for 6 wk instead of Dbol/Anadrol. Tbol provides regular strength gains without massive retention, moderate hepatotoxicity vs other orals. 'Clean' profile for visual strength. Sobolevsky 2012 documents long-term metabolites (12-18 month detection — not for tested athletes).

Dose / Duration

Test enanthate 500 mg/wk for 12 wk + Turinabol 60 mg/d during W1-W6 (kickstart). AI as needed. Hepatoprotectors W1-W6. Classic PCT.

Target audience

Intermediate powerlifters and strongmen (3+ cycles), seeking a 'clean' oral kickstart, solid baseline liver, athletes in untested sport. Not for tested athletes (Tbol detectable very long).

Pros

+ Milder oral than Dbol/Anadrol
+ No massive retention
+ Regular strength gains
+ Clean visual effect
+ Moderate cost

Cons

− Moderate hepatotoxicity (17α-alkylated)
− Degraded lipid profile
− Very long anti-doping detection (Sobolevsky 2012)
− Raw effect inferior to Anadrol
− Black market: frequent counterfeits

10. Sustanon 500 + Boldenone 600 + M1T 10 mg/d — the "EQ strength stack"

Variant oriented toward Boldenone (Equipoise) for endurance and appetite, combined with a 'designer steroid' oral like methyl-1-testosterone (M1T) at low dose. M1T is extremely potent per mg but severely hepatotoxic. Limit to 10 mg/d for 4 wk max. Aggressive profile on strength and endurance, suited to strongman. Critical liver bloodwork.

Dose / Duration

Sustanon 500 mg/wk + Boldenone undecylenate 600 mg/wk for 14-16 wk + M1T 10 mg/d during W1-W4. AI mandatory. Very high-dose hepatoprotectors. Demanding PCT with pre-PCT hCG.

Target audience

Elite strongmen accepting M1T risk profile, long strongman off-season, monthly biological monitoring. Strictly not recommended outside professional strongman competitive profile.

Pros

+ Endurance + strength effect (Boldenone)
+ M1T extremely potent per mg
+ Suited to strongman (endurance event)
+ Increased erythropoiesis (Bold)
+ Appetite effect (useful strongman caloric intake)

Cons

− M1T among the most severe hepatotoxicity
− Very elevated hematocrit (probable phlebotomies)
− Elevated blood pressure
− Long cycle (14-16 wk) — significant commitment
− Catastrophic lipid profile

Final comparison

Stack	1RM bench gain 8 wk	Joints	Weight category	Safety
Test + Anadrol	+15-25 kg	Lubricated (water)	Marked change	Medium-low
Test + Tren A	+15-25 kg	Dry (risk)	Stable	Low
Test + Tren + Anadrol	+20-35 kg	Mixed	Variable	Very low
Test + Deca + Dbol	+15-25 kg	Very good (deca)	Marked change	Low
Test + Halotestin	+10-20 kg	Dry (risk)	Stable	Low (liver)
Test 900 mg/wk solo	+15-25 kg	Lubricated	Moderate change	Medium
Test + Primo + Anavar	+10-15 kg	Good	Stable	Good
Test + Tren E (steady)	+12-20 kg	Moderately dry	Stable	Medium
Test + Turinabol	+12-20 kg	Neutral	Moderate	Medium
Sustanon + EQ + M1T	+15-25 kg	Good (EQ)	Marked change	Very low (M1T)

FAQ

Which cycle gains the most absolute strength?: The Test + Tren + Anadrol combo remains historically the most effective for absolute strength (+20-35 kg on 3 lifts in 12 wk in advanced users). Mechanisms: Test provides androgen base and erythropoiesis, Tren amplifies neural drive and tissue-selective protein synthesis (Yarrow 2011), Anadrol kickstarts joint and glycogen hydration for immediate explosiveness. Very heavy risk profile: blood pressure, liver, lipids, ASIH. Reserved for elite competitors accepting this profile and with strict monitoring. For the majority, Test E 500 + Sustanon 500 (effective 900 mg/wk) or Test + moderate Tren offer 80% of the result with less risk.
AAS and tendons: rupture risk?: Real and documented. AAS amplify muscle strength faster than tendon resistance adapts — imbalance risk of rupture on absolute loads. Particularly marked with Winstrol and Halotestin (dry synovial structures), less with testosterone alone. Cohort studies (Sader 2001) suggest altered collagen quality under chronic AAS. Precautions: (1) Progressive load on cycle (don't attempt 1RM too early). (2) Extensive warmup (15-20 min). (3) 'Lubricating' compounds (Deca, Primo) if joint history. (4) Joint support: hydrolyzed collagen 15 g/d, omega-3 3 g/d, vitamin C 1 g/d, hydration +1L/d.
Strength cycle vs mass cycle: differences?: Main differences: (1) Favored compounds: strength cycles oriented toward Tren, Anadrol, Halotestin, strong Test base; mass cycles toward Test + Deca, moderate Test + Dbol, Primo. (2) Training programming: strength = moderate volume, intensity 85-95% 1RM, long rest; mass = high volume, intensity 65-80% 1RM, moderate rest. (3) Nutrition: strength = moderate surplus (+200-300 kcal), elevated protein 2.2-2.5 g/kg; mass = generous surplus (+400-600 kcal), protein 2 g/kg. (4) Duration: strength = short intense cycles (8-12 wk); mass = long cycles (12-16 wk). (5) PCT: strength requires faster neural recovery, pre-PCT hCG often useful.
Tested powerlifting: possible with AAS?: Not without sporting risk. Tested federations (IPF, USAPL pre-2021, WPC) use WADA-compliant controls (Sobolevsky 2012 on long-term Turinabol metabolites — 12-18 month detection). All AAS are on the WADA S1 list, variable but often long detection. Strategies (for record, not recommended): prolonged pause (>18 months) before tested competition, very short cycles with short esters (test propionate), short-detection half-life molecules. In practice: if you want to compete tested, stay natural. If you want to compete with AAS, choose untested federations (USPA, WPO, GPC, strongman federations).
How to manage blood pressure on strength cycle?: Critical surveillance. Heavy strength stacks (Tren, Anadrol, M1T) systematically elevate blood pressure (Hartgens 2004, Baggish 2017). Monitoring: daily morning + evening readings at rest over 5 min. Targets: <140/90, ideally <130/85. If sustained BP >150/95: (1) Reduce dose. (2) Add telmisartan 20-40 mg/d (often used bodybuilding, ideal medical supervision). (3) Optimize sleep 8h, sodium <4 g/d, hydration. (4) Cardio LISS 3x/wk 30 min. If repeat BP >160/100: cycle stop, consultation. Lifestyle factors: coffee, sleep, stress, salt — all matter.
Halotestin: rational use?: Strictly reserved for last 2-4 wk pre-meet, dose 10-20 mg/d. Beneficial effect: absolute strength +5-10% by neural drive and subjective confidence without mass gain (so stable weight category). Risk profile: among the highest hepatotoxicity of orals (Hudson 1959, Niedfeldt 2018), sometimes excessive marked aggression ('halo-rage'), catastrophic lipid profile. Precautions: weekly ALT/AST, high-dose hepatoprotectors (TUDCA 1000 mg/d, NAC 1800 mg/d), stop 3-5 days before meet to eliminate hepatic peak. Not in off-season or outside competition.
What role for peptides in strength cycle?: Complementary. GH-stimulating peptides (Ipamorelin, GHRP-2, CJC-1295) improve inter-session recovery and deep sleep — indirect benefits on strength (optimized neural recovery). Oral MK-677 provides same effects without injection. BPC-157 useful in post-joint or tendon injury rehabilitation, frequent in heavy powerlifters and strongmen. IGF-1 LR3 adds direct anabolic effect but hypoglycemia risk. In practice: Ipamorelin 100 µg x 2/d routine good option, BPC-157 250 µg/d targeted recovery if injury. No replacement for AAS for absolute strength.
Strength cycle after 40: adaptations?: Specific master recommendations. (1) Prefer mild compounds (moderate Test E 400-500 mg/wk, add Primo 400 mg/wk or Anavar 30 mg/d) rather than Tren/Anadrol. (2) Shorter cycles (8-10 wk) with longer offs. (3) Reinforced cardiovascular monitoring (ECG, echocardiography if history). (4) Systematic joint support (collagen, omega-3, glucosamine). (5) Sleep priority (8h+, GH secretagogues useful). (6) Bloodwork every 3 months (including PSA). (7) Consider medicalized blast & cruise with permanent TRT rather than repeated cycles with PCT in >45 (Bhasin 2018). Absolute strength is less than at 25, but progression still possible.